Cargando…

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al

Detalles Bibliográficos
Autores principales: Titanji, Boghuma K, Farley, Monica M, Schinazi, Raymond F, Marconi, Vincent C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454400/
https://www.ncbi.nlm.nih.gov/pubmed/32797226
http://dx.doi.org/10.1093/cid/ciaa1210
_version_ 1783575495277805568
author Titanji, Boghuma K
Farley, Monica M
Schinazi, Raymond F
Marconi, Vincent C
author_facet Titanji, Boghuma K
Farley, Monica M
Schinazi, Raymond F
Marconi, Vincent C
author_sort Titanji, Boghuma K
collection PubMed
description
format Online
Article
Text
id pubmed-7454400
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74544002020-08-31 Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al Titanji, Boghuma K Farley, Monica M Schinazi, Raymond F Marconi, Vincent C Clin Infect Dis Online Only Articles Oxford University Press 2020-08-14 /pmc/articles/PMC7454400/ /pubmed/32797226 http://dx.doi.org/10.1093/cid/ciaa1210 Text en Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Online Only Articles
Titanji, Boghuma K
Farley, Monica M
Schinazi, Raymond F
Marconi, Vincent C
Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title_full Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title_fullStr Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title_full_unstemmed Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title_short Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
title_sort response to correspondence: baricitinib: impact on coronavirus disease 2019 (covid-19) coagulopathy? jorgensen et al
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454400/
https://www.ncbi.nlm.nih.gov/pubmed/32797226
http://dx.doi.org/10.1093/cid/ciaa1210
work_keys_str_mv AT titanjiboghumak responsetocorrespondencebaricitinibimpactoncoronavirusdisease2019covid19coagulopathyjorgensenetal
AT farleymonicam responsetocorrespondencebaricitinibimpactoncoronavirusdisease2019covid19coagulopathyjorgensenetal
AT schinaziraymondf responsetocorrespondencebaricitinibimpactoncoronavirusdisease2019covid19coagulopathyjorgensenetal
AT marconivincentc responsetocorrespondencebaricitinibimpactoncoronavirusdisease2019covid19coagulopathyjorgensenetal